Highly Brominated Quinolines: Synthesis, Characterization, and Investigation of Anticancer Activities Supported by Molecular Dynamics

IF 3.3 4区 医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY
Osman Çakmak, Salih Ökten, Tuğba Kul Köprülü, Cenk A. Andac, Şaban Tekin, Seyfullah Oktay Arslan
{"title":"Highly Brominated Quinolines: Synthesis, Characterization, and Investigation of Anticancer Activities Supported by Molecular Dynamics","authors":"Osman Çakmak,&nbsp;Salih Ökten,&nbsp;Tuğba Kul Köprülü,&nbsp;Cenk A. Andac,&nbsp;Şaban Tekin,&nbsp;Seyfullah Oktay Arslan","doi":"10.1111/cbdd.70120","DOIUrl":null,"url":null,"abstract":"<p>In this study, we synthesized and characterized novel brominated methoxyquinolines (<b>7</b> and <b>11</b>) and nitrated bromoquinoline (<b>17</b>) derivatives with potential antiproliferative activity against cancer cell lines. Starting from 1,2,3,4-tetrahydroquinoline (THQ, <b>1</b>), a series of brominated quinoline compounds was obtained via regioselective bromination and subsequent reactions. The structure of the key compound, 3,5,6,7-tetrabromo-8-methoxyquinoline (<b>7</b>), was confirmed using 1D and 2D NMR techniques. Additionally, unexpected bromination of 3,6,8-trimethoxyquinoline (<b>5</b>) yielded 5,7-dibromo-3,6-dimethoxy-8-hydroxyquinoline (<b>11</b>), allowing functionalization of both rings in the quinoline. The direct nitration of 6,8-dibromoquinoline (<b>6</b>) yielded the corresponding 5-nitro derivative (<b>17</b>), a precursor to amino derivatives that activate the bromine group on the ring. Antiproliferative activities of these derivatives (<b>7</b>, <b>11</b>, <b>17</b>) were assessed against C6, HeLa, and HT29 cancer cell lines using the BCPE assay. Compounds <b>7</b>, <b>11</b>, and <b>17</b> exhibited significant inhibitory effects, with compound <b>11</b> showing the highest activity (IC<sub>50</sub> values of 5.45–9.6 μg/mL). Furthermore, the cytotoxicity of these compounds was evaluated using the LDH assay, indicating lower cytotoxic effects compared to the control drug 5-FU. The ability of compounds <b>11</b> and <b>17</b> to induce apoptosis was confirmed through DNA laddering, while compound <b>7</b> showed no such effect. Compounds <b>7</b> and <b>11</b> inhibited human topoisomerase I, a critical enzyme for DNA replication and repair, with significant binding energies determined by MM-PBSA studies. The wound healing assay demonstrated that compound <b>17</b> effectively inhibited the migration of HT29 cells. These findings highlight the potential of these novel quinoline derivatives as effective anticancer agents, warranting further investigation into their mechanisms of action and therapeutic applications.</p>","PeriodicalId":143,"journal":{"name":"Chemical Biology & Drug Design","volume":"105 5","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cbdd.70120","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chemical Biology & Drug Design","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cbdd.70120","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

In this study, we synthesized and characterized novel brominated methoxyquinolines (7 and 11) and nitrated bromoquinoline (17) derivatives with potential antiproliferative activity against cancer cell lines. Starting from 1,2,3,4-tetrahydroquinoline (THQ, 1), a series of brominated quinoline compounds was obtained via regioselective bromination and subsequent reactions. The structure of the key compound, 3,5,6,7-tetrabromo-8-methoxyquinoline (7), was confirmed using 1D and 2D NMR techniques. Additionally, unexpected bromination of 3,6,8-trimethoxyquinoline (5) yielded 5,7-dibromo-3,6-dimethoxy-8-hydroxyquinoline (11), allowing functionalization of both rings in the quinoline. The direct nitration of 6,8-dibromoquinoline (6) yielded the corresponding 5-nitro derivative (17), a precursor to amino derivatives that activate the bromine group on the ring. Antiproliferative activities of these derivatives (7, 11, 17) were assessed against C6, HeLa, and HT29 cancer cell lines using the BCPE assay. Compounds 7, 11, and 17 exhibited significant inhibitory effects, with compound 11 showing the highest activity (IC50 values of 5.45–9.6 μg/mL). Furthermore, the cytotoxicity of these compounds was evaluated using the LDH assay, indicating lower cytotoxic effects compared to the control drug 5-FU. The ability of compounds 11 and 17 to induce apoptosis was confirmed through DNA laddering, while compound 7 showed no such effect. Compounds 7 and 11 inhibited human topoisomerase I, a critical enzyme for DNA replication and repair, with significant binding energies determined by MM-PBSA studies. The wound healing assay demonstrated that compound 17 effectively inhibited the migration of HT29 cells. These findings highlight the potential of these novel quinoline derivatives as effective anticancer agents, warranting further investigation into their mechanisms of action and therapeutic applications.

Abstract Image

高溴化喹啉:分子动力学支持下抗癌活性的合成、表征和研究
在这项研究中,我们合成并鉴定了具有潜在抗癌活性的新型溴化甲氧喹啉(7和11)和硝化溴喹啉(17)衍生物。从1,2,3,4-四氢喹啉(THQ, 1)开始,通过区域选择性溴化及后续反应得到了一系列溴化喹啉化合物。关键化合物3,5,6,7-四溴-8-甲氧基喹啉(7)的结构通过一维和二维核磁共振技术得到了证实。此外,3,6,8-三甲氧基喹啉(5)的意外溴化生成5,7-二溴-3,6-二甲氧基-8-羟基喹啉(11),使得喹啉的两个环都能功能化。直接硝化6,8-二溴喹啉(6)产生相应的5-硝基衍生物(17),这是激活环上溴基团的氨基衍生物的前体。这些衍生物(7,11,17)对C6, HeLa和HT29癌细胞系的抗增殖活性使用BCPE试验进行了评估。化合物7、11、17均表现出明显的抑制作用,其中化合物11的IC50值为5.45 ~ 9.6 μg/mL,活性最高。此外,这些化合物的细胞毒性使用LDH测定法进行评估,表明与对照药物5-FU相比,细胞毒性作用更低。通过DNA阶梯法证实了化合物11和17诱导细胞凋亡的能力,而化合物7则没有这种作用。化合物7和11抑制人类拓扑异构酶I,这是DNA复制和修复的关键酶,通过MM-PBSA研究确定了显著的结合能。伤口愈合实验表明,化合物17能有效抑制HT29细胞的迁移。这些发现突出了这些新型喹啉衍生物作为有效抗癌药物的潜力,值得对其作用机制和治疗应用进行进一步研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Chemical Biology & Drug Design
Chemical Biology & Drug Design 医学-生化与分子生物学
CiteScore
5.10
自引率
3.30%
发文量
164
审稿时长
4.4 months
期刊介绍: Chemical Biology & Drug Design is a peer-reviewed scientific journal that is dedicated to the advancement of innovative science, technology and medicine with a focus on the multidisciplinary fields of chemical biology and drug design. It is the aim of Chemical Biology & Drug Design to capture significant research and drug discovery that highlights new concepts, insight and new findings within the scope of chemical biology and drug design.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信